NM_001388492.1:c.6591G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001388492.1(HTT):​c.6591G>A​(p.Glu2197Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 1,613,220 control chromosomes in the GnomAD database, including 74,997 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 6032 hom., cov: 33)
Exomes 𝑓: 0.30 ( 68965 hom. )

Consequence

HTT
NM_001388492.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0900

Publications

19 publications found
Variant links:
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
  • Huntington disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • Lopes-Maciel-Rodan syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • juvenile Huntington disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 4-3212105-G-A is Benign according to our data. Variant chr4-3212105-G-A is described in ClinVar as Benign. ClinVar VariationId is 1599468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.09 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.376 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTTNM_001388492.1 linkc.6591G>A p.Glu2197Glu synonymous_variant Exon 48 of 67 ENST00000355072.11 NP_001375421.1
HTTNM_002111.8 linkc.6591G>A p.Glu2197Glu synonymous_variant Exon 48 of 67 NP_002102.4 P42858

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTTENST00000355072.11 linkc.6591G>A p.Glu2197Glu synonymous_variant Exon 48 of 67 1 NM_001388492.1 ENSP00000347184.5 P42858

Frequencies

GnomAD3 genomes
AF:
0.265
AC:
40291
AN:
152050
Hom.:
6028
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.146
Gnomad AMI
AF:
0.230
Gnomad AMR
AF:
0.261
Gnomad ASJ
AF:
0.306
Gnomad EAS
AF:
0.391
Gnomad SAS
AF:
0.193
Gnomad FIN
AF:
0.441
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.307
Gnomad OTH
AF:
0.225
GnomAD2 exomes
AF:
0.295
AC:
73558
AN:
249314
AF XY:
0.289
show subpopulations
Gnomad AFR exome
AF:
0.138
Gnomad AMR exome
AF:
0.295
Gnomad ASJ exome
AF:
0.300
Gnomad EAS exome
AF:
0.391
Gnomad FIN exome
AF:
0.436
Gnomad NFE exome
AF:
0.302
Gnomad OTH exome
AF:
0.290
GnomAD4 exome
AF:
0.303
AC:
442319
AN:
1461052
Hom.:
68965
Cov.:
35
AF XY:
0.299
AC XY:
217239
AN XY:
726770
show subpopulations
African (AFR)
AF:
0.131
AC:
4397
AN:
33470
American (AMR)
AF:
0.288
AC:
12861
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.300
AC:
7836
AN:
26132
East Asian (EAS)
AF:
0.385
AC:
15266
AN:
39680
South Asian (SAS)
AF:
0.190
AC:
16363
AN:
86240
European-Finnish (FIN)
AF:
0.426
AC:
22747
AN:
53364
Middle Eastern (MID)
AF:
0.130
AC:
748
AN:
5758
European-Non Finnish (NFE)
AF:
0.310
AC:
344696
AN:
1111334
Other (OTH)
AF:
0.288
AC:
17405
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
15788
31577
47365
63154
78942
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11342
22684
34026
45368
56710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.265
AC:
40307
AN:
152168
Hom.:
6032
Cov.:
33
AF XY:
0.266
AC XY:
19769
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.146
AC:
6046
AN:
41526
American (AMR)
AF:
0.261
AC:
3987
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.306
AC:
1063
AN:
3470
East Asian (EAS)
AF:
0.390
AC:
2020
AN:
5180
South Asian (SAS)
AF:
0.192
AC:
926
AN:
4824
European-Finnish (FIN)
AF:
0.441
AC:
4663
AN:
10570
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.307
AC:
20859
AN:
68002
Other (OTH)
AF:
0.232
AC:
490
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1494
2987
4481
5974
7468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
424
848
1272
1696
2120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.283
Hom.:
2993
Bravo
AF:
0.248
Asia WGS
AF:
0.313
AC:
1088
AN:
3478
EpiCase
AF:
0.293
EpiControl
AF:
0.289

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.61
DANN
Benign
0.26
PhyloP100
0.090
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs362336; hg19: chr4-3213832; COSMIC: COSV61870515; API